Patent · US Active

Modified phosphatases

US8557545B2 · kind B2 · utility

10Cited by

1References

15Claims

0Family size

Assignee

AM-Pharma B.V. · NL

Inventors

Markwin Paul Velders · Forest Park, US
Luigi Johannes Cornelius Jonk · Utrecht, NL
Willem Raaben · Amersfoort, NL
Marty Bernardus Fransiscus Wulferink · Ede, NL

Key dates

Filing date	Apr 25, 2008
Grant date	Oct 15, 2013
Priority date	—
Expiry date	Apr 23, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to phosphatases and more in specific to (genetically) modified phosphatases, pharmaceutical compositions comprising (genetically) modified phosphatases and the use of (genetically) modified phosphatases for treating or curing for example sepsis, inflammatory bowel disease or other inflammatory diseases, or renal failure. The invention further relates to a method for producing phosphatases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.